ATA803679A - METHOD FOR PRODUCING GALENIC PREPARATIONS - Google Patents

METHOD FOR PRODUCING GALENIC PREPARATIONS

Info

Publication number
ATA803679A
ATA803679A AT0803679A AT803679A ATA803679A AT A803679 A ATA803679 A AT A803679A AT 0803679 A AT0803679 A AT 0803679A AT 803679 A AT803679 A AT 803679A AT A803679 A ATA803679 A AT A803679A
Authority
AT
Austria
Prior art keywords
galenic preparations
producing
producing galenic
preparations
galenic
Prior art date
Application number
AT0803679A
Other languages
German (de)
Other versions
AT372279B (en
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of ATA803679A publication Critical patent/ATA803679A/en
Application granted granted Critical
Publication of AT372279B publication Critical patent/AT372279B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/48Ergoline derivatives, e.g. lysergic acid, ergotamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891Coated capsules; Multilayered drug free capsule shells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5015Organic compounds, e.g. fats, sugars
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5036Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5036Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
AT0803679A 1978-12-21 1979-12-20 METHOD FOR PRODUCING GALENIC PREPARATIONS AT372279B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH1301978 1978-12-21
CH1302178 1978-12-21
CH56779 1979-01-19
CH56679 1979-01-19

Publications (2)

Publication Number Publication Date
ATA803679A true ATA803679A (en) 1983-02-15
AT372279B AT372279B (en) 1983-09-26

Family

ID=27427929

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0803679A AT372279B (en) 1978-12-21 1979-12-20 METHOD FOR PRODUCING GALENIC PREPARATIONS

Country Status (23)

Country Link
AT (1) AT372279B (en)
AU (1) AU534051B2 (en)
CA (1) CA1139222A (en)
CH (1) CH642259A5 (en)
CY (1) CY1330A (en)
DE (1) DE2950154A1 (en)
DK (1) DK154607C (en)
FI (1) FI793888A (en)
FR (1) FR2444463A1 (en)
GB (1) GB2038181B (en)
HK (1) HK37986A (en)
HU (1) HU182577B (en)
IE (1) IE49323B1 (en)
IL (1) IL59003A (en)
IT (1) IT1164029B (en)
KE (1) KE3617D (en)
MY (1) MY8500129A (en)
NL (1) NL187229C (en)
NZ (1) NZ192457A (en)
PH (1) PH25178A (en)
PT (1) PT70614A (en)
SE (1) SE442265B (en)
WO (1) WO1980001242A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0064485B1 (en) * 1981-04-27 1985-07-24 Aktiebolaget Hässle New pharmaceutical preparation
US4366145A (en) * 1981-06-24 1982-12-28 Sandoz, Inc. Soft gelatin capsule with a liquid ergot alkaloid center fill solution and method of preparation
HU192050B (en) * 1983-04-22 1987-05-28 Sandoz Ag Process for production of medical preparative containing co-dergocrin and one piridin-dicarbonic acid diesthertype calcium-antagonist
DE3413955A1 (en) * 1983-04-22 1984-10-25 Sandoz-Patent-GmbH, 7850 Lörrach Pharmaceutical product containing co-dergocrine and a calcium antagonist
NL194389C (en) * 1984-06-14 2002-03-04 Novartis Ag Process for preparing a solid dispersion of a pharmaceutically active agent that has low water solubility in a solid matrix of a water-soluble polyalkylene glycol as a carrier.
GB8426922D0 (en) * 1984-10-24 1984-11-28 Sandoz Ltd Galenic formulation
AT388101B (en) * 1985-02-05 1989-05-10 Sandoz Ag Process for the production of a pharmaceutical composition for oral administration with controlled release of active ingredient
CN1003978B (en) * 1987-09-05 1989-04-26 广州陈李济药厂 Preparing process of stomach-solvable type and intestinn-solvable type integsated pill-ready-made traditional chinese medicine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3432593A (en) * 1963-09-18 1969-03-11 Key Pharm Inc Delayed and sustained release type pharmaceutical preparation
DE2528257C2 (en) * 1974-07-04 1986-02-13 Sandoz-Patent-GmbH, 7850 Lörrach New galenic preparation
DE2546577B2 (en) * 1975-10-17 1981-04-02 Sandoz-Patent-GmbH, 7850 Lörrach Solid substances made from polyvinylpyrrolidone and ergot alkaloids

Also Published As

Publication number Publication date
AU5403179A (en) 1980-06-26
NL7909105A (en) 1980-06-24
GB2038181A (en) 1980-07-23
MY8500129A (en) 1985-12-31
PH25178A (en) 1991-03-27
CY1330A (en) 1986-06-27
FI793888A (en) 1980-06-22
FR2444463A1 (en) 1980-07-18
DK529879A (en) 1980-06-22
DK154607B (en) 1988-12-05
FR2444463B1 (en) 1983-02-25
DE2950154C2 (en) 1989-05-11
SE7910227L (en) 1980-06-22
DK154607C (en) 1989-06-05
GB2038181B (en) 1983-05-11
WO1980001242A1 (en) 1980-06-26
IE49323B1 (en) 1985-09-18
IE792471L (en) 1980-06-21
AU534051B2 (en) 1984-01-05
IT7951153A0 (en) 1979-12-20
HK37986A (en) 1986-05-30
NL187229C (en) 1991-07-16
CH642259A5 (en) 1984-04-13
NZ192457A (en) 1983-06-17
DE2950154A1 (en) 1980-07-10
AT372279B (en) 1983-09-26
CA1139222A (en) 1983-01-11
PT70614A (en) 1980-01-01
IT1164029B (en) 1987-04-08
IL59003A (en) 1982-12-31
HU182577B (en) 1984-02-28
KE3617D (en) 1986-04-18
SE442265B (en) 1985-12-16

Similar Documents

Publication Publication Date Title
AT364451B (en) METHOD FOR PRODUCING LOCALANETHETICALLY EFFECTIVE COMBINATION PREPARATIONS
AT358022B (en) METHOD FOR PRODUCING (S) ALPHA-CYANO-3- -PHENOXYBENZYL ALCOHOL
ATA729079A (en) METHOD FOR PRODUCING MONALDEHYDES
AT369366B (en) METHOD FOR PRODUCING LYSERGOL DERIVATIVES
AT371097B (en) METHOD FOR PRODUCING O-METHALLYLOXYPHENOL
ATA311179A (en) METHOD FOR PRODUCING 6ALPHA-HALOGEN -PREGNADIEN-DERIVATES
AT374486B (en) METHOD FOR PRODUCING 17BETA-HYDROXY-17
AT372279B (en) METHOD FOR PRODUCING GALENIC PREPARATIONS
AT365452B (en) METHOD FOR PRODUCING PHARMACEUTICAL PREPARATIONS
AT380701B (en) METHOD FOR PRODUCING MONOFILES
ATA663779A (en) METHOD FOR PRODUCING 3-EXOMETHYL ENCEPHAMSULFOXIDESTERS
AT363186B (en) METHOD FOR PRODUCING GLYCOSIDES
AT369728B (en) METHOD FOR PRODUCING TRICHLORAETHYLENE
AT367017B (en) METHOD FOR PRODUCING P-AMINO-DIPHENYLAMINE
AT369355B (en) METHOD FOR PRODUCING 2'-DIAETHYLAMINO-1'METHYL [THYL-2-HYDROXY-2-CYCLOHEXYL OR -2-PHENYL-CYCLOHEXANCARBOXYLATE
AT372380B (en) METHOD FOR PRODUCING 7-HYDROXYCUMARINE DERIVATIVES
ATA339979A (en) METHOD FOR PRODUCING DRAWBORE
AT371710B (en) METHOD FOR PRODUCING GALENIC PREPARATIONS
AT376439B (en) METHOD FOR PRODUCING ERGOTAL CALALID
AT370422B (en) METHOD FOR PRODUCING VINDESINMONOSULFATE
ATA254579A (en) METHOD FOR PRODUCING 2-MERCAPTOBENZTHIAZOL
DD136833A1 (en) METHOD FOR PRODUCING POLYAETHERALCOOHOLES
AT357547B (en) METHOD FOR PRODUCING 3-PHENYL-PYRIDAZONE- (6)
AT370759B (en) METHOD FOR PRODUCING BITUMEN PREPARATIONS
ATA136279A (en) METHOD FOR PRODUCING PHARMACEUTICAL PREPARATIONS